Eric Trachtenberg's Net Worth
$630 Thousand
Who is Eric Trachtenberg?
Eric Trachtenberg does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Kala Pharmaceuticals, Inc., Aralez Pharmaceuticals Inc., and POZEN INC /NC.
SEC CIK
Eric Trachtenberg's CIK is 0001646300
Past Insider Trading and Trends
2016 was Eric Trachtenberg's most active year for acquiring shares with 5 total transactions. Eric Trachtenberg's most active month to acquire stocks was the month of December. 2023 was Eric Trachtenberg's most active year for disposing of shares, totalling 8 transactions. Eric Trachtenberg's most active month to dispose stocks was the month of April. 2020 saw Eric Trachtenberg paying a total of $149,996.19 for 225,901 shares, this is the most they've acquired in one year. In 2021 Eric Trachtenberg cashed out on 11,901 shares for a total of $31,156.24, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
KALA BIO, Inc. (KALA) Snapshot price: $6.96
SEE REMARKS
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +5.21% | 3.37K |
$6.74 | -$8,269.98 | 68.07K |
Jan 4
| |||
Form 4
| +138.42% | 37.56K |
—
|
—
| 64.69K |
Jun 22
| |||
Form 4
| +136.05% | 15.64K |
—
|
—
| 27.13K |
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 14
| |||
Form 4
| +466.26% | 9.46K |
$28.55 | -$1,713.00 | 11.49K |
Scheduled
|
Jan 4
| ||
Form 4
| -8.72% | -194.00 |
$6.52 | -$1,264.88 | 2.03K |
Scheduled
|
Oct 26
| ||
Form 4
| -2.30% | -2.61K |
$0.37 | -$966.81 | 111.2K |
Scheduled
|
Jun 27
| ||
Form 4
| -2.44% | -2.85K |
$1.30 | -$3,705.00 | 113.82K |
Scheduled
|
Jan 3 - Jan 4
| ||
Form 4
| -7.49% | -9.45K |
$1.80 | -$17,008.20 | 116.67K |
Scheduled
|
Oct 26
| ||
Form 4
| -1.91% | -2.45K |
$5.77 | -$14,148.04 | 126.11K |
Scheduled
|
Jun 28
| ||
Form 4
| +21.40% | 22.67K |
—
|
—
| 128.57K |
Jan 4
| |||
Form 4
| +135.85% | 61K |
—
|
—
| 105.9K |
Oct 26
| |||
Form 4
| +55.36% | 16K |
—
|
—
| 44.9K |
Jun 25
| |||
Form 4
|
∞
| 28.9K |
$5.19 | $149,996.19 | 28.9K |
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aralez Pharmaceuticals Inc. No price found
GC, CCO & Secretary
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.72% | -3.47K |
$1.70 | -$5,900.70 | 198.09K |
Scheduled
|
Mar 19
| ||
Form 4
| -3.69% | -7.72K |
$1.33 | -$10,267.60 | 201.56K |
Scheduled
|
Jun 23
| ||
Form 4
| +44.83% | 64.78K |
—
|
—
| 209.28K |
May 11
| |||
Form 4
| +7.43% | 10K |
$3.76 | $37,570.00 | 144.5K |
May 16
| |||
Form 4
| +34.50% | 34.5K |
—
|
—
| 134.5K |
Mar 17
| |||
Form 4
| +300.00% | 75K |
—
|
—
| 100K |
Feb 12
| |||
Form 4
|
∞
| 25K |
—
|
—
| 25K |
Feb 5
| |||
| No matching records found | |||||||||
POZEN INC /NC No price found
Deputy General Counsel
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 25K |
—
|
—
| 25K |
Jun 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||